TNYA vs. CRDL
TNYA (Tenaya Therapeutics, Inc.) and CRDL (Cardiol Therapeutics Inc Class A) are both stocks. Both are in the Healthcare sector — TNYA in Biotechnology, CRDL in Drug Manufacturers - Specialty & Generic. Over the past 3 years, TNYA returned -45.81%/yr vs 5.92%/yr for CRDL. At a 0.20 correlation, their price movements are largely independent.
Performance
TNYA vs. CRDL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TNYA achieves a 22.33% return, which is significantly higher than CRDL's 5.89% return.
TNYA
- 1D
- 2.40%
- 1M
- 22.28%
- 6M
- 13.84%
- YTD
- 22.33%
- 1Y
- 27.40%
- 3Y*
- -45.81%
- 5Y*
- —
- 10Y*
- —
CRDL
- 1D
- 1.81%
- 1M
- -1.94%
- 6M
- 1.27%
- YTD
- 5.89%
- 1Y
- -21.71%
- 3Y*
- 5.92%
- 5Y*
- -15.54%
- 10Y*
- —
TNYA vs. CRDL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
TNYA Tenaya Therapeutics, Inc. | 22.33% | -50.24% | -55.86% | 61.19% | -89.39% | -2.82% |
CRDL Cardiol Therapeutics Inc Class A | 5.89% | -25.48% | 51.80% | 65.33% | -72.43% | -12.41% |
Correlation
The correlation between TNYA and CRDL is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Jul 30, 2021 | 0.20 |
Fundamentals
TNYA:
$145.01M
CRDL:
$116.42M
TNYA:
-$0.47
CRDL:
-CA$0.37
TNYA:
1.78
CRDL:
8.02
TNYA:
$225.00K
CRDL:
CA$0.00
TNYA:
$0.00
CRDL:
-CA$25.95K
TNYA:
-$78.62M
CRDL:
-CA$34.00M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TNYA vs. CRDL — Risk / Return Rank
TNYA
CRDL
TNYA vs. CRDL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tenaya Therapeutics, Inc. (TNYA) and Cardiol Therapeutics Inc Class A (CRDL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TNYA | CRDL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.64 | ||
| Sortino ratioReturn per unit of downside risk | +1.41 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 0.98 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | 0.36 | -0.67 | +1.03 |
| Martin ratioReturn relative to average drawdown | 0.53 | -0.92 | +1.44 |
Loading charts...
Drawdowns
TNYA vs. CRDL - Drawdown Comparison
The maximum TNYA drawdown since its inception was -98.69%, which is greater than CRDL's maximum drawdown of -92.71%. Use the drawdown chart below to compare losses from any high point for TNYA and CRDL.
Loading charts...
Drawdown Indicators
| TNYA | CRDL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.69% | -92.71% | -5.98% |
Max Drawdown (1Y)Largest decline over 1 year | -73.81% | -39.48% | -34.33% |
Max Drawdown (3Y)Largest decline over 3 years | -94.30% | -72.73% | -21.57% |
Max Drawdown (5Y)Largest decline over 5 years | — | -90.72% | — |
Current DrawdownCurrent decline from peak | -97.06% | -83.68% | -13.38% |
Average DrawdownAverage peak-to-trough decline | -82.37% | -69.12% | -13.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 50.52% | 28.71% | +21.81% |
Volatility
TNYA vs. CRDL - Volatility Comparison
Tenaya Therapeutics, Inc. (TNYA) has a higher volatility of 17.60% compared to Cardiol Therapeutics Inc Class A (CRDL) at 9.49%. This indicates that TNYA's price experiences larger fluctuations and is considered to be riskier than CRDL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TNYA | CRDL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.60% | 9.49% | +8.11% |
Volatility (6M)Calculated over the trailing 6-month period | 69.93% | 40.25% | +29.68% |
Volatility (1Y)Calculated over the trailing 1-year period | 109.55% | 66.79% | +42.76% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 108.74% | 86.93% | +21.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 108.74% | 86.55% | +22.19% |
Dividends
TNYA vs. CRDL - Dividend Comparison
Neither TNYA nor CRDL has paid dividends to shareholders.
Financials
TNYA vs. CRDL - Financials Comparison
This section allows you to compare key financial metrics between Tenaya Therapeutics, Inc. and Cardiol Therapeutics Inc Class A. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
TNYA and CRDL have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TNYA has higher volatility (17.60%) compared to CRDL (9.49%). In terms of maximum drawdown, TNYA dropped -98.69% vs CRDL's -92.71%.
TNYA currently has the higher Sharpe Ratio (0.24 vs -0.39), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TNYA and CRDL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer